Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Complementary alternative medicine and nuclear medicineUrsula Werneke, V Ralph McCreadyCancer Biotherapy & Radiopharmaceuticals|May 5, 2005
The potential use of 99mTc-MDP bone scans to plan high-activity 186Re-HEDP targeted therapy of bony metastases from prostate cancerDavid Binnie, Antigoni Divoli, V Ralph McCready, et al.The British Journal of Radiology|January 3, 2018
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapyAna M Denis-Bacelar, Sarah J Chittenden, V Ralph McCready, et al.Nuclear Medicine Communications|January 9, 2015
Early gated SPECT adenosine myocardial perfusion imaging may influence the therapeutic management of patients with coronary artery diseaseSabina Dizdarevic, Nitasha Singh, Sunil Nair, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2016
Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survivalAna M Denis-Bacelar, Sarah J Chittenden, David P Dearnaley, et al.Physics in Medicine and Biology|March 15, 2017
A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastasesAna M Denis-Bacelar, Sarah J Chittenden, Iain Murray, et al.Nuclear Medicine Communications|February 19, 2024
The British nuclear medicine research strategy - the frameworkSabina Dizdarevic, V Ralph Mccready, Philip J Blower, et al.Pageof 1